Wells Fargo & Company CHECKMATE PHARMACEUTICALS IN Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
N/A
-33 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
N/A
1 Added 3.13%
33 $0
Q2 2021

Aug 16, 2021
SELL
N/A
-2,823 Reduced 98.88%
32 $0
Q1 2021

May 13, 2021
BUY
N/A
148 Added 5.47%
2,855 $35,000
Q4 2020

Feb 09, 2021
BUY
N/A
1,303 Added 92.81%
2,707 $39,000
Q3 2020

Nov 05, 2020
BUY
N/A
1,404 New
1,404 $16,000
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email